ACUR OTC
Acura Pharmaceuticals, Inc.
1W: -1.0%
1M: -0.0%
3M: -88.9%
YTD: -80.0%
1Y: -75.0%
3Y: -99.8%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$742K
-3.2% ▼
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$742K
-3.2% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$348K
+22.5% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$6M | -$4M | -$4M | -$1M | -$879K |
| Depreciation & Amort. | $294K | $280K | $273K | $125K | $90K |
| Stock-Based Comp. | $500K | $230K | $108K | $36K | $58K |
| Change in Working Capital | $367K | -$152K | $121K | -$117K | $477K |
| Other Non-Cash Items | $11K | -$424K | $3M | $445K | -$488K |
| Operating Cash Flow | -$5M | -$4M | -$618K | -$719K | -$742K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $309K | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $309K | $0 | $0 | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | -$3M | $2M | $1M | $269K | $399K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | -$2K | -$8K |
| Financing Cash Flow | $1M | $2M | $1M | $270K | $394K |
| Net Change in Cash | -$3M | -$2M | $771K | -$449K | -$348K |
| Cash End of Period | $2M | $91K | $862K | $413K | $65K |
| Free Cash Flow | -$5M | -$4M | -$618K | -$719K | -$742K |